According to a 2024 survey by Morgan Stanley Research, 59% of individuals on anti-obesity medication are drinking more tap or still water, 66% are consuming less soda and alcohol, and 38% are increasing their intake of protein beverages
Vomiting was also more frequent in the GLP-1RA group (10.7 days/1000 patient-days vs 0.3 days/1000 patient-days), and reduced appetite occurred at an incidence rate of 183 days/1000 patient-days in the GLP-1RA group compared to 10.7 days/1000 patient-days in the control group
Mounjaro and Zepbound are other similar drugs
doi: 10.1177/1359105314532153
Physicians find once monthly GLP-1 analog as an exciting option for patients assuming safety, cardiovascular benefits, and efficacy remain on par to current existing products
Transitional cell urethral carcinomas can also be confused with poorly differentiated solid variants of SCC